Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDLÆGESELSKABET MOLS TANDKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.1% 1.0% 1.0% 1.1% 0.9% 1.1% 19.4% 19.1%   Credit score (0-100)   86 87 87 82 90 82 6 7   Credit rating   A A A A A A B B   Credit limit (kDKK)   58.4 81.7 113.0 57.5 160.8 66.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,042 2,902 3,139 3,046 3,388 3,190 0.0 0.0   EBITDA   610 606 774 697 893 807 0.0 0.0   EBIT   477 477 663 580 755 671 0.0 0.0   Pre-tax profit (PTP)   475.8 476.0 657.2 572.1 747.7 668.5 0.0 0.0   Net earnings   370.8 371.2 512.5 455.1 583.0 521.3 0.0 0.0   Pre-tax profit without non-rec. items   476 476 657 572 748 668 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   766 637 551 708 570 434 0.0 0.0   Shareholders equity total   637 638 781 726 859 800 30.1 30.1   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,226 1,161 1,392 1,252 1,475 1,307 30.1 30.1   Net Debt   -138 -272 -520 -189 -511 -521 -30.1 -30.1     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,042 2,902 3,139 3,046 3,388 3,190 0.0 0.0   Gross profit growth   7.8% -4.6% 8.2% -3.0% 11.2% -5.9% -100.0% 0.0%   Employees   5 5 5 5 5 4 0 0   Employee growth %   25.0% 0.0% 0.0% 0.0% 0.0% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,226 1,161 1,392 1,252 1,475 1,307 30 30   Balance sheet change%   -10.7% -5.3% 19.9% -10.1% 17.8% -11.4% -97.7% 0.0%   Added value   610.2 606.4 773.9 696.5 871.5 807.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -267 -258 -198 41 -277 -273 -434 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.7% 16.4% 21.1% 19.0% 22.3% 21.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.8% 40.1% 51.9% 44.0% 55.4% 48.3% 0.0% 0.0%   ROI %   60.9% 69.4% 86.5% 71.2% 88.2% 76.0% 0.0% 0.0%   ROE %   58.3% 58.2% 72.2% 60.4% 73.6% 62.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   51.9% 55.0% 56.1% 58.0% 58.2% 61.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -22.6% -44.9% -67.2% -27.1% -57.2% -64.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.6 0.8 1.3 0.9 1.4 1.6 0.0 0.0   Current Ratio   0.8 1.0 1.5 1.1 1.6 1.8 0.0 0.0   Cash and cash equivalent   138.1 272.3 520.4 188.8 511.5 521.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -114.6 20.3 253.9 49.2 314.8 378.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   122 121 155 139 174 202 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   122 121 155 139 179 202 0 0   EBIT / employee   95 95 133 116 151 168 0 0   Net earnings / employee   74 74 103 91 117 130 0 0